Product Description
Overall, the global transcatheter embolization market was valued at over $1.5 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.4% to reach nearly $2.1 billion.
The full report suite on the global market for transcatheter embolization includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2032, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Transcatheter Embolization Market Trends
Detachable coils are priced higher than pushable coils and offer the advantage of being retractable after deployment, a feature not available with pushable coils. Despite their higher cost, the increased versatility of detachable coils drives faster growth in this segment compared with the more affordable pushable coil market.
Global Transcatheter Embolization Market Share Insights
- Boston Scientific retained the Contour® PVA Embolization Particles and expanded its portfolio with TheraSpheres® and DC-Beads®, entering the drug-eluting and radioactive particle segments. In 2025, the company held a leading position in the coil embolic market, competing closely with Cook Medical. Its offerings include pushable coils such as the VortX® 18 and 35 Vascular Occlusion Coils, featuring a conical design for complete vessel occlusion, as well as detachable coils like the Interlock-35™ Fibered IDC™ Occlusion System. With physician preference increasingly favoring detachable coils, Boston Scientific’s market share is expected to grow modestly over the forecast period.
- Medtronic offers the Concerto™ detachable coil system and the Onyx® Liquid Embolic System. The Onyx® system uses a polymer dissolved in dimethyl sulfoxide to solidify upon injection, forming an occlusion. It comes in two formulations, Onyx® 18 and Onyx® 34. While approved for treating intracranial arteriovenous malformations (AVMs), it is often used off-label for peripheral AVMs and endoleaks from abdominal aortic aneurysm (AAA) stent graft procedures. Medtronic faced a lawsuit settlement in the U.S. in 2018 related to previous off-label sales of the Onyx® system by its former manufacturer, ev3.
- Sirtex Medical was the leading player in the niche radioactive particle market, holding a substantial share of this high-value segment. The company secured reimbursement approval for its SIRSpheres® in France and for selective internal radiation therapy in the United Kingdom. By June 2019, Sirtex had reached the milestone of delivering 100,000 patient doses of SIRSpheres®.
Global Transcatheter Embolization Market Segmentation Summary
- Vascular Closure Device Market – Further Segmented Into:
- Device Type: Non-Invasive, and Invasive.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
